Position in BLLN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,496,173
-$293,673 QoQ
Shares Held
44,289
-4.4% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026LORD, ABBETT & CO. LLC holds $835,881,937 across 12 Diagnostics & Research names. BLLN ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,111,505 | $222,289,884 | |
| 2 | GH |
Guardant Health, Inc.
|
1,899,113 | $175,421,067 | |
| 3 | LH |
Labcorp Holdings Inc.
|
585,844 | $156,309,037 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
537,725 | $91,703,621 | |
| 5 | DHR |
Danaher Corp /De/
|
331,282 | $62,811,067 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
88,247 | $49,585,106 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
3,536,103 | $49,081,109 | |
| 8 | A |
Agilent Technologies, Inc.
|
117,762 | $13,422,512 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,496,173 | 44,289 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,789,846 | 46,308 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||